Gabrielle Sulzberger - 31 Dec 2022 Form 5 Insider Report for Cerevel Therapeutics Holdings, Inc.

Role
Director
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2022
Net transactions value
$0
Form type
5
Filing time
14 Feb 2023, 16:47:00 UTC
Previous filing
20 Dec 2022
Next filing
19 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERE Common Stock Gift $0 -49,624 -78% $0.000000 14,270 03 Oct 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.